-
1
-
-
33646058566
-
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
-
Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367:1247-1255.
-
(2006)
Lancet
, vol.367
, pp. 1247-1255
-
-
Harper, D.M.1
Franco, E.L.2
Wheeler, C.M.3
Moscicki, A.B.4
Romanowski, B.5
Roteli-Martins, C.M.6
-
2
-
-
34249689698
-
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 viruslike particle (VLP) vaccine
-
Olsson S.E., Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Malm C., et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 viruslike particle (VLP) vaccine. Vaccine 2007, 25:4931-4939.
-
(2007)
Vaccine
, vol.25
, pp. 4931-4939
-
-
Olsson, S.E.1
Villa, L.L.2
Costa, R.L.3
Petta, C.A.4
Andrade, R.P.5
Malm, C.6
-
3
-
-
79955029503
-
-
Haute Autorité de santé - État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France - Argumentaire (French), ; [accessed 20.11.10].
-
Haute Autorité de santé - État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France - Argumentaire (French), ; [accessed 20.11.10]. http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/argumentaire_recommandations_depistage_cancer_du_col_de_luterus.pdf.
-
-
-
-
4
-
-
79955030847
-
-
Avis du Comité Technique des Vaccinations et du Conseil Supérieur d'Hygiène Publique de France, Section des Maladies Transmissibles, relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18 (French), 9 March [accessed 3.08.10].
-
Avis du Comité Technique des Vaccinations et du Conseil Supérieur d'Hygiène Publique de France, Section des Maladies Transmissibles, relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18 (French), 9 March 2007; [accessed 3.08.10]. http://www.hcsp.fr/docspdf/cshpf/a_mt_090307_papillomavirus.pdf.
-
(2007)
-
-
-
5
-
-
79955023457
-
-
Haut Conseil de la santé publique - Avis relatif à la vaccination contre les papillomavirus humains 16 et 18 par un vaccin bivalent (French), 14 December; [accessed 3.08.10].
-
Haut Conseil de la santé publique - Avis relatif à la vaccination contre les papillomavirus humains 16 et 18 par un vaccin bivalent (French), 14 December 2007; [accessed 3.08.10]. http://www.hcsp.fr/hcspi/docspdf/avisrapports/hcspa20071214_Papillomavirus.pdf.
-
(2007)
-
-
-
6
-
-
79955012423
-
-
Haut Conseil de la santé publique - Avis relatif à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23ans (French), 17 December; [accessed 26.01.11].
-
Haut Conseil de la santé publique - Avis relatif à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23ans (French), 17 December 2010; [accessed 26.01.11]. http://www.hcsp.fr/docspdf/avisrapports/hcspa20101217_ppmvjf1423.pdf.
-
(2010)
-
-
-
7
-
-
79955034108
-
-
L'assurance maladie en ligne - Statistiques et publications. MEDIC'AM(French), ; [accessed 20.11.10].
-
L'assurance maladie en ligne - Statistiques et publications. MEDIC'AM 2004-2009 (French), ; [accessed 20.11.10]. http://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/donnees-statistiques/medic-am-generic-am-biolam-lpp-am/medic-am-2004-2009.php.
-
(2004)
-
-
-
8
-
-
77649224129
-
Pharmacoepidemiological research using French reimbursement databases: yes we can!
-
Martin-Latry K., Bégaud B. Pharmacoepidemiological research using French reimbursement databases: yes we can!. Pharmacoepidemiol Drug Saf 2010, 19:256-265.
-
(2010)
Pharmacoepidemiol Drug Saf
, vol.19
, pp. 256-265
-
-
Martin-Latry, K.1
Bégaud, B.2
-
9
-
-
77955589546
-
French national health insurance information system and the permanent beneficiaries sample
-
Tuppin P., de Roquefeuil L., Weill A., Ricordeau P., Merlière Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique 2010, 58:286-290.
-
(2010)
Rev Epidemiol Sante Publique
, vol.58
, pp. 286-290
-
-
Tuppin, P.1
de Roquefeuil, L.2
Weill, A.3
Ricordeau, P.4
Merlière, Y.5
-
10
-
-
79955016010
-
-
National Institute of Statistics and Economic Studies, The French civil status statistics system, ; [accessed 3.08.10].
-
National Institute of Statistics and Economic Studies, The French civil status statistics system, ; [accessed 3.08.10]. http://www.insee.fr/en/themes/detail.asp%3Fref_id=ir-sd2005%26page=irweb/sd2005/dd/doc/source22.htm.
-
-
-
-
11
-
-
79955033778
-
-
National Institute of Statistics and Economic Studies.
-
National Institute of Statistics and Economic Studies Demographic balance sheet 2009, http://www.insee.fr/en/themes/theme.asp?theme=2&sous_theme=1; [accessed 3.08.10].
-
(2009)
Demographic balance sheet
-
-
-
12
-
-
79954999157
-
-
European Medicines Agency, Gardasil: EPAR - Product Information. ; [accessed 3.08.10].
-
European Medicines Agency, Gardasil: EPAR - Product Information. ; [accessed 3.08.10]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000703/WC500021142.pdf.
-
-
-
-
13
-
-
79954999846
-
-
European Medicines Agency. Cervarix: EPAR - Product Information, ; [accessed 03.08.10].
-
European Medicines Agency. Cervarix: EPAR - Product Information, ; [accessed 03.08.10]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000721/WC500024632.pdf.
-
-
-
-
14
-
-
79954996526
-
-
European Cervical Cancer Association, HPV Vaccination Across Europe, ; [accessed 3.08.10].
-
European Cervical Cancer Association, HPV Vaccination Across Europe, ; [accessed 3.08.10]. http://www.ecca.info/fileadmin/user_upload/HPV_Vaccination/ECCA_HPV_Vaccination_April_2009.pdf.
-
-
-
-
15
-
-
70349256456
-
-
Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2008, MMWR Morb Mortal Wkly Rep; 58: 997-1001, ; [accessed 03.08.10].
-
Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2008, MMWR Morb Mortal Wkly Rep 2009; 58: 997-1001, ; [accessed 03.08.10]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5836a2.htm.
-
(2009)
-
-
-
16
-
-
77955928840
-
-
Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years - United States, 2009, MMWR Morb Mortal Wkly Rep
-
Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years - United States, 2009, MMWR Morb Mortal Wkly Rep 2010; 59: 1018-23, ; [accessed 10.10.10]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5932a3.htm.
-
(2010)
, vol.59
, pp. 1018-1023
-
-
-
17
-
-
79954998185
-
-
Department of Health, Annual HPV vaccine uptake in England: 2008/09, ; [accessed 03.08.10].
-
Department of Health, Annual HPV vaccine uptake in England: 2008/09, ; [accessed 03.08.10]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111676.pdf.
-
-
-
-
18
-
-
79954999844
-
-
HPV Vaccination Programme: Provisional data, as submitted by PCTs, for First and Second dose vaccine uptake, for the month ending 28 February [accessed 03.08.10].
-
HPV Vaccination Programme: Provisional data, as submitted by PCTs, for First and Second dose vaccine uptake, for the month ending 28 February 2010, ; [accessed 03.08.10]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_115153.pdf.
-
(2010)
-
-
-
19
-
-
65549142194
-
Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia
-
Brotherton J.M., Deeks S.L., Campbell-Lloyd S., Misrachi A., Passaris I., Peterson K., et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008, 32:457-461.
-
(2008)
Commun Dis Intell
, vol.32
, pp. 457-461
-
-
Brotherton, J.M.1
Deeks, S.L.2
Campbell-Lloyd, S.3
Misrachi, A.4
Passaris, I.5
Peterson, K.6
-
20
-
-
79955038931
-
-
Conseil Supérieur D'hygiène Publique de France, Comité Technique Des Vaccinations, Groupe de Travail sur la vaccination contre les papillomavirus, 23 March final version (French). ; [accessed 03.08.10].
-
Conseil Supérieur D'hygiène Publique de France, Comité Technique Des Vaccinations, Groupe de Travail sur la vaccination contre les papillomavirus, 23 March 2007 final version (French). ; [accessed 03.08.10]. http://www.sante.gouv.fr/dossiers/cshpf/r_mt_230307_papillomavirus.pdf.
-
(2007)
-
-
-
21
-
-
79955025459
-
-
Modélisation médico-économique de l'impact de l'organisation du dépistage du cancer du col utérin et de l'introduction de la vaccination contre les HPV dans le calendrier vaccina
-
Dervaux B, Lenne X, Lévy-Bruhl D, Kudjawu Y. Modélisation médico-économique de l'impact de l'organisation du dépistage du cancer du col utérin et de l'introduction de la vaccination contre les HPV dans le calendrier vaccinal, Mars 2007 (French), ; [accessed 20.11.10]. http://www.invs.sante.fr/publications/2008/modelisation_hpv/rapport_modelisation_hpv.pdf.
-
-
-
Dervaux, B.1
Lenne, X.2
Lévy-Bruhl, D.3
Kudjawu, Y.4
-
22
-
-
0033947903
-
Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis
-
Myers E.R., McCrory D.C., Nanda K., Bastian L., Matchar D.B. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000, 151:1158-1171.
-
(2000)
Am J Epidemiol
, vol.151
, pp. 1158-1171
-
-
Myers, E.R.1
McCrory, D.C.2
Nanda, K.3
Bastian, L.4
Matchar, D.B.5
-
23
-
-
38549164676
-
Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
-
Bergeron C., Largeron N., McAllister R., Mathevet P., Remy V. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France. Int J Technol Assess Health Care 2008, 24:10-19.
-
(2008)
Int J Technol Assess Health Care
, vol.24
, pp. 10-19
-
-
Bergeron, C.1
Largeron, N.2
McAllister, R.3
Mathevet, P.4
Remy, V.5
-
24
-
-
50849119746
-
Modeling cervical cancer prevention in developed countries
-
Kim J.J., Brisson M., Edmunds W.J., Goldie S.J. Modeling cervical cancer prevention in developed countries. Vaccine 2008, 26(Suppl. 10):K76-K86.
-
(2008)
Vaccine
, vol.26
, Issue.SUPPL. 10
-
-
Kim, J.J.1
Brisson, M.2
Edmunds, W.J.3
Goldie, S.J.4
-
25
-
-
44349147211
-
Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
-
Szucs T.D., Largeron N., Dedes K.J., Rafia R., Bénard S. Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Curr Med Res Opin 2008, 24:1473-1483.
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 1473-1483
-
-
Szucs, T.D.1
Largeron, N.2
Dedes, K.J.3
Rafia, R.4
Bénard, S.5
-
26
-
-
52949147772
-
Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
-
Usher C., Tilson L., Olsen J., Jepsen M., Walsh C., Barry M. Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model. Vaccine 2008, 26:5654-5661.
-
(2008)
Vaccine
, vol.26
, pp. 5654-5661
-
-
Usher, C.1
Tilson, L.2
Olsen, J.3
Jepsen, M.4
Walsh, C.5
Barry, M.6
-
27
-
-
49549088827
-
Economic evaluation of human papillomavirus vaccination in the United Kingdom
-
Jit M., Choi Y.H., Edmunds W.J. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008, 337:331-335.
-
(2008)
BMJ
, vol.337
, pp. 331-335
-
-
Jit, M.1
Choi, Y.H.2
Edmunds, W.J.3
-
28
-
-
77953554172
-
Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
-
Olsen J., Jepsen M.R. Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark. Int J Technol Assess Health Care 2010, 26:183-191.
-
(2010)
Int J Technol Assess Health Care
, vol.26
, pp. 183-191
-
-
Olsen, J.1
Jepsen, M.R.2
-
29
-
-
77952355761
-
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types
-
Armstrong E.P. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm 2010, 16:217-230.
-
(2010)
J Manag Care Pharm
, vol.16
, pp. 217-230
-
-
Armstrong, E.P.1
-
30
-
-
77649271813
-
Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK
-
Cuzick J., Castañón A., Sasieni P. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer 2010, 102:933-939.
-
(2010)
Br J Cancer
, vol.102
, pp. 933-939
-
-
Cuzick, J.1
Castañón, A.2
Sasieni, P.3
-
31
-
-
79954987881
-
-
Vaccination coverage of children and adolescents in France: results of school-based surveys, (French), ; [accessed 20.11.10].
-
Antona D, Fonteneau L, Lévy-Bruhl D, Guignon N, De Peretti C, Niel X, et al. Vaccination coverage of children and adolescents in France: results of school-based surveys, 2001-2004 (French), ; [accessed 20.11.10]. http://www.invs.sante.fr/BEh/2007/06/beh_06_2007.pdf.
-
(2001)
-
-
Antona, D.1
Fonteneau, L.2
Lévy-Bruhl, D.3
Guignon, N.4
De Peretti, C.5
Niel, X.6
-
33
-
-
73749086154
-
Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program
-
Mehu-Parant F., Rouzier R., Soulat J.M., Parant O. Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program. Eur J Obstet Gynecol Reprod Biol 2010, 148:186-190.
-
(2010)
Eur J Obstet Gynecol Reprod Biol
, vol.148
, pp. 186-190
-
-
Mehu-Parant, F.1
Rouzier, R.2
Soulat, J.M.3
Parant, O.4
|